Article Versions Notes

Grimmichova T, Pacesova P, Hill M, Pekova B, Vankova M, Moravcova J, Vrbikova J, Novak Z, Mastnikova K, Vaclavikova E, et al. Thyroid Cancer Detection in a Routine Clinical Setting: Performance of ACR TI-RADS, FNAC, and Molecular Testing in Prospective Cohort Study. Biomedicines. 2022; 10(5):954. https://doi.org/10.3390/biomedicines10050954

Grimmichova, Tereza, Petra Pacesova, Martin Hill, Barbora Pekova, Marketa Vankova, Jitka Moravcova, Jana Vrbikova, Zdenek Novak, Karolina Mastnikova, Eliska Vaclavikova, and et al. 2022. "Thyroid Cancer Detection in a Routine Clinical Setting: Performance of ACR TI-RADS, FNAC, and Molecular Testing in Prospective Cohort Study" Biomedicines 10, no. 5: 954. https://doi.org/10.3390/biomedicines10050954

Grimmichova, T., Pacesova, P., Hill, M., Pekova, B., Vankova, M., Moravcova, J., Vrbikova, J., Novak, Z., Mastnikova, K., Vaclavikova, E., Vcelak, J., Bendlova, B., Drozenova, J., & Sykorova, V. (2022). Thyroid Cancer Detection in a Routine Clinical Setting: Performance of ACR TI-RADS, FNAC, and Molecular Testing in Prospective Cohort Study. Biomedicines, 10(5), 954. https://doi.org/10.3390/biomedicines10050954